Basic Information
RNALocate ID: | RLID:11000869 |
RNA Symbol: | hsa-miR-26b-5p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-26b |
RNA ID: | miRBase:MIMAT0000083 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 20615901 |
Tissue/Cell Line: | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) |
Method: | Microarray|RT-PCR |
Originally published in Nucleic Acids Res. Wang K, et al, 2010. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | These observations of miRNA distribution demonstrate that the miRNA export system in the cells must somehow be able to target specific miRNAs to specific extracellular structures, but does not exclusively channel specific miRNAs to a given fraction. There are, however, some miRNAs that are found in the supernatant almost to the exclusion of all other fractions (miR-219 in A549 culture medium, Figure 4b, for example). Another significant observation from this data is that even though we showed that the two cell lines studied here export a similar spectrum of miRNAs (Figure 1b) the distributions of miRNAs from the two cell lines demonstrate clear differences, as shown in Figure 4b and c. For example, miR-145 is present at very low levels in HepG2 derived microvesicles (Figure 4c), while the same miRNA is present at significant levels in both A549 derived microvesicles and exosomes (Figure 4b). On the other hand, there are some miRNAs, notably those that are almost uniformly distributed among the fractions, with the same distribution no matter which cell-line is the source. These observations certainly indicate the degree of complexity of this export system that will bear further investigation. Data are collected from Figure 4. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001357 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001358 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001359 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001360 | Nucleus | Colon adenocarcinoma cells | 20864815 |
RLID:11000861 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11000862 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11000863 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11000864 | Exosome | Renal cancer cells | 21670082 |
RLID:11000865 | Exosome | Breast milk | 22211110 |
RLID:11000866 | Exosome | Brain tissue | 23382797 |
RLID:11000867 | Exosome | Plasma | 23663360 |
RLID:11000868 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11000870 | Microvesicle | Plasma | 23077538 |
RLID:11000871 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000019 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000282 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-26b-5p | Diffuse large b cell lymphoma | MNDR-E-MI-33339 |
MNDR | hsa-miR-26b-5p | Splenic marginal zone lymphoma | MNDR-E-MI-33340 |
MNDR | hsa-miR-26b-5p | Oral squamous cell carcinoma | MNDR-E-MI-33341 |
MNDR | hsa-miR-26b-5p | Large cell neuroendocrine cancer | MNDR-E-MI-33342 |
MNDR | hsa-miR-26b-5p | Medulloblastoma | MNDR-E-MI-33343 |
MNDR | hsa-miR-26b-5p | B cell lymphoma of malt type | MNDR-E-MI-33344 |
MNDR | hsa-miR-26b-5p | Ovarian clear cell carcinoma | MNDR-E-MI-33345 |
MNDR | hsa-miR-26b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-33346 |
MNDR | hsa-miR-26b-5p | Lymphoma | MNDR-E-MI-33347 |
MNDR | hsa-miR-26b-5p | Lymphoma non-hodgkin | MNDR-E-MI-33348 |
MNDR | hsa-miR-26b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-33349 |
MNDR | hsa-miR-26b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-33350 |
MNDR | hsa-miR-26b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-33351 |
MNDR | hsa-miR-26b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-33352 |
MNDR | hsa-miR-26b-5p | Breast cancer luminal | MNDR-E-MI-33353 |
MNDR | hsa-miR-26b-5p | Niemann-pick disease type c | MNDR-E-MI-33354 |
MNDR | hsa-miR-26b-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-33355 |
MNDR | hsa-miR-26b-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-33356 |
MNDR | hsa-miR-26b-5p | Dermatomyositis | MNDR-E-MI-33357 |
MNDR | hsa-miR-26b-5p | Prostate cancer | MNDR-E-MI-33358 |
MNDR | hsa-miR-26b-5p | Gastric cancer | MNDR-E-MI-33359 |
MNDR | hsa-miR-26b-5p | Gastric lymphoma | MNDR-E-MI-33360 |
MNDR | hsa-miR-26b-5p | Alzheimer disease | MNDR-E-MI-33361 |
MNDR | hsa-miR-26b-5p | Intracranial aneurysm | MNDR-E-MI-33362 |
MNDR | hsa-miR-26b-5p | Urinary bladder cancer | MNDR-E-MI-33363 |
MNDR | hsa-miR-26b-5p | Esophageal carcinoma | MNDR-E-MI-33364 |
MNDR | hsa-miR-26b-5p | Dysautonomia familial | MNDR-E-MI-33365 |
MNDR | hsa-miR-26b-5p | Head and neck cancer | MNDR-E-MI-33366 |
MNDR | hsa-miR-26b-5p | Lewy body dementia | MNDR-E-MI-33367 |
MNDR | hsa-miR-26b-5p | Leukemia | MNDR-E-MI-33368 |
MNDR | hsa-miR-26b-5p | Cardiovascular disease | MNDR-E-MI-33369 |
MNDR | hsa-miR-26b-5p | Lung cancer | MNDR-E-MI-33370 |
MNDR | hsa-miR-26b-5p | Parkinson disease | MNDR-E-MI-33371 |
MNDR | hsa-miR-26b-5p | Niemann-pick disease | MNDR-E-MI-33372 |
MNDR | hsa-miR-26b-5p | Breast cancer | MNDR-E-MI-33373 |
MNDR | hsa-miR-26b-5p | Pituitary neoplasms | MNDR-E-MI-33374 |
MNDR | hsa-miR-26b-5p | Pancreatic cancer | MNDR-E-MI-33375 |
MNDR | hsa-miR-26b-5p | Melanoma | MNDR-E-MI-33376 |
MNDR | hsa-miR-26b-5p | Rectum adenocarcinoma | MNDR-E-MI-33377 |
MNDR | hsa-miR-26b-5p | Nephroblastoma | MNDR-E-MI-33378 |
MNDR | hsa-miR-26b-5p | Colon cancer | MNDR-E-MI-33379 |
MNDR | hsa-miR-26b-5p | Colon adenocarcinoma | MNDR-E-MI-33380 |
MNDR | hsa-miR-26b-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-33381 |
MNDR | hsa-miR-26b-5p | Ovarian cancer | MNDR-E-MI-33382 |
MNDR | hsa-miR-26b-5p | Prostate adenocarcinoma | MNDR-E-MI-33383 |
MNDR | hsa-miR-26b-5p | Laryngeal carcinoma | MNDR-E-MI-33384 |
MNDR | hsa-miR-26b-5p | Kidney cancer | MNDR-E-MI-33385 |
MNDR | hsa-miR-26b-5p | Glioblastoma | MNDR-E-MI-33386 |
MNDR | hsa-miR-26b-5p | Glioma | MNDR-E-MI-33387 |
MNDR | hsa-miR-26b-5p | Oligodendroglioma | MNDR-E-MI-33388 |
MNDR | hsa-miR-26b-5p | Central nervous system lymphoma | MNDR-E-MI-33389 |
MNDR | hsa-miR-26b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-33390 |
MNDR | hsa-miR-26b-5p | Epilepsy temporal lobe | MNDR-E-MI-33391 |
MNDR | hsa-miR-26b-5p | Osteosarcoma | MNDR-E-MI-33392 |
MNDR | hsa-miR-26b-5p | Inclusion body myositis | MNDR-E-MI-33393 |
MNDR | hsa-miR-26b-5p | Meningioma | MNDR-E-MI-33394 |
MNDR | hsa-miR-26b-5p | Liver cancer | MNDR-E-MI-33395 |
MNDR | hsa-miR-26b-5p | Cervical adenocarcinoma | MNDR-E-MI-33396 |
MNDR | hsa-miR-26b-5p | Gastric adenocarcinoma | MNDR-E-MI-33397 |
MNDR | hsa-miR-26b-5p | Cervical squamous cell carcinoma | MNDR-E-MI-33398 |
MNDR | hsa-miR-26b-5p | Pituitary adenoma | MNDR-E-MI-33399 |
MNDR | hsa-miR-26b-5p | Lung squamous cell carcinoma | MNDR-E-MI-33400 |
MNDR | hsa-miR-26b-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-33401 |
MNDR | hsa-miR-26b-5p | Lung adenocarcinoma | MNDR-E-MI-33402 |
MNDR | hsa-miR-26b-5p | Thyroid carcinoma | MNDR-E-MI-33403 |
MNDR | hsa-miR-26b-5p | Ovarian carcinoma | MNDR-E-MI-33404 |
MNDR | hsa-miR-26b-5p | Carcinoma renal cell | MNDR-E-MI-33405 |
MNDR | hsa-miR-26b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-33406 |
MNDR | hsa-miR-26b-5p | Renal clear cell carcinoma | MNDR-E-MI-33407 |
MNDR | hsa-miR-26b-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-33408 |
MNDR | hsa-miR-26b-5p | Cholangiocarcinoma | MNDR-E-MI-33409 |
MNDR | hsa-miR-26b-5p | Lung small cell carcinoma | MNDR-E-MI-33410 |
MNDR | hsa-miR-26b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-33411 |
MNDR | hsa-miR-26b-5p | T acute lymphoblastic leukemia | MNDR-E-MI-33412 |
MNDR | hsa-miR-26b-5p | Acute t cell leukemia | MNDR-E-MI-33413 |
MNDR | hsa-miR-26b-5p | Acute heart failure | MNDR-E-MI-33414 |
MNDR | hsa-miR-26b-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-33415 |
MNDR | hsa-miR-26b-5p | Early hepatocellular carcinoma | MNDR-E-MI-33416 |
MNDR | hsa-miR-26b-5p | B-cell lymphoma | MNDR-E-MI-33417 |
MNDR | hsa-miR-26b-5p | Rheumatoid arthritis | MNDR-E-MI-33418 |
MNDR | hsa-miR-26b-5p | T-cell leukemia | MNDR-E-MI-33419 |
MNDR | hsa-miR-26b-5p | Neuroblastoma | MNDR-E-MI-33420 |
MNDR | hsa-miR-26b-5p | Barrett's adenocarcinoma | MNDR-E-MI-33421 |
MNDR | hsa-miR-26b-5p | Osteoarthritis | MNDR-E-MI-33422 |
MNDR | hsa-miR-26b-5p | Hodgkin lymphoma | MNDR-E-MI-33423 |
MNDR | hsa-miR-26b-5p | Ulcerative colitis | MNDR-E-MI-33424 |
MNDR | hsa-miR-26b-5p | Burkitt lymphoma | MNDR-E-MI-33425 |
MNDR | hsa-miR-26b-5p | Dementia vascular | MNDR-E-MI-33426 |
MNDR | hsa-miR-26b-5p | Psoriasis | MNDR-E-MI-33427 |
MNDR | hsa-miR-26b-5p | Acute myelocytic leukemia | MNDR-E-MI-33428 |
MNDR | hsa-miR-26b-5p | Colorectal cancer | MNDR-E-MI-33429 |
MNDR | hsa-miR-26b-5p | Nasopharynx carcinoma | MNDR-E-MI-33430 |
MNDR | hsa-miR-26b-5p | Multiple myeloma | MNDR-E-MI-33431 |
MNDR | hsa-miR-26b-5p | Acute lymphocytic leukemia | MNDR-E-MI-33432 |
MNDR | hsa-miR-26b-5p | Ovarian epithelial cancer | MNDR-E-MI-33433 |
MNDR | hsa-miR-26b-5p | Cardiomegaly | MNDR-E-MI-33434 |
MNDR | hsa-miR-26b-5p | Nasopharyngeal cancer | MNDR-E-MI-33435 |
MNDR | hsa-miR-26b-5p | Stroke lacunar | MNDR-E-MI-33436 |
MNDR | hsa-miR-26b-5p | Barrett's carcinogenesis | MNDR-E-MI-33437 |
MNDR | hsa-miR-26b-5p | Breast cancer her3+ negative | MNDR-E-MI-33438 |
MNDR | hsa-miR-26b-5p | High grade dysplastic nodule | MNDR-E-MI-33439 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCA1 | Homo sapiens | RR00022108 |
TOP